Lee's Pharmaceutical Holdings Limited Stock
Stocks
950
KYG5438W1116
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
11:32:57 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.195 HKD | +0.00% |
|
-1.24% | -21.38% |
| 09-10 | Lee's Pharma Licenses Cancer Drug OC-3 From 1cBio; Shares Plummet 4% | MT |
| 08-31 | Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 724M 92.35M 81.23M 76.58M 69.86M 131M 8.86B 132M 919M 356M 4.51B 347M 339M 14.68B | P/E 2024 |
8.98x | P/E 2025 | 9.74x |
|---|---|---|---|---|---|
| Enterprise Value | 685M 87.3M 76.79M 72.39M 66.04M 124M 8.38B 124M 869M 337M 4.26B 328M 321M 13.88B | EV / Sales 2024 |
0.6x | EV / Sales 2025 | 0.6x |
| Free-Float |
50.73% | Yield 2024 |
3.17% | Yield 2025 | 2.96% |
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 950 | Delayed | |
Deutsche Boerse AG
| L1PA | Delayed | |
|
Börse Stuttgart
| L1PA | Delayed |
| 1 week | -1.24% | ||
| Current month | -7.00% | ||
| 1 month | +7.66% | ||
| 3 months | +10.65% | ||
| 6 months | -5.91% | ||
| Current year | -21.38% |
| 1 week | 1.16 |  | 1.25 |
| 1 month | 1.1 | | 1.42 |
| Current year | 0.99 | | 1.69 |
| 1 year | 0.99 | | 2.41 |
| 3 years | 0.99 | | 2.7 |
| 5 years | 0.99 | | 4.14 |
| 10 years | 0.99 | | 14.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 73 | 01/04/1997 | |
Yiu Ming Chow
DFI | Director of Finance/CFO | 53 | 07/10/2014 |
Sze Ka Wong
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Siu Fong Lee
CHM | Chairman | 70 | 05/04/2010 |
| Director/Board Member | 73 | 01/12/2001 | |
Xiao Yi Li
BRD | Director/Board Member | 63 | 01/09/2003 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/05/26 | Other | Chief Executive Officer | 41,500 | 0.0070% | ||
| 28/05/26 | Other | Chief Executive Officer | 200,000 | 0.0340% | ||
| 15/10/25 | Other | Chief Executive Officer | 588,000 | 0.0999% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.00% | -1.24% | -48.04% | -4.40% | 92.35M | |
| +2.68% | +2.56% | +59.32% | +114.68% | 1,053B | |
| +0.56% | +0.17% | +53.19% | +68.65% | 652B | |
| +0.02% | +0.42% | +20.51% | +73.58% | 468B | |
| -0.25% | +1.91% | +42.59% | +45.70% | 351B | |
| +0.24% | +3.65% | +21.73% | +28.97% | 273B | |
| +0.77% | +0.11% | +14.22% | +11.79% | 254B | |
| -0.01% | +6.91% | +45.42% | +51.68% | 220B | |
| -1.11% | -0.80% | +31.69% | +99.56% | 186B | |
| -0.22% | -10.44% | -30.17% | -60.43% | 170B | |
| Average | -0.00% | +1.11% | +21.05% | +42.98% | 362.75B | |
| Weighted average by Cap. | +0.07% | +1.00% | +39.15% | +67.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.4B 179M 157M 148M 135M 253M 17.14B 255M 1.78B 688M 8.72B 670M 656M 28.38B | 1.44B 183M 161M 152M 139M 259M 17.58B 261M 1.82B 706M 8.95B 687M 673M 29.11B |
| Net income | 93.1M 11.87M 10.44M 9.84M 8.98M 16.79M 1.14B 16.93M 118M 45.77M 580M 44.57M 43.6M 1.89B | 91.94M 11.72M 10.31M 9.72M 8.87M 16.59M 1.13B 16.71M 117M 45.2M 573M 44.01M 43.06M 1.86B |
| Net Debt | 10.45M 1.33M 1.17M 1.11M 1.01M 1.89M 128M 1.9M 13.26M 5.14M 65.12M 5M 4.9M 212M | -39.63M -5.05M -4.44M -4.19M -3.82M -7.15M -485M -7.2M -50.28M -19.48M -247M -18.97M -18.56M -803M |
Employees
1,137
Sector
Pharmaceuticals
Calendar
08:00am
Ex-dividend date - 0.035 HKD
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | HK$1.195 | +0.00% | 339,000 |
| 24/09/26 | HK$1.230 | +0.82% | 315,500 |
| 23/09/26 | HK$1.220 | +0.83% | 348,000 |
| 22/09/26 | HK$1.210 | +0.41% | 343,000 |
| 21/09/26 | HK$1.205 | -0.41% | 473,500 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 950 Stock
Select your edition
All financial news and data tailored to specific country editions
